Milestone Scientific Inc. (MLSS) |
| 0.387 -0.013 (-3.23%) 05-29 16:00 |
| Open: | 0.382 |
| High: | 0.3917 |
| Low: | 0.3778 |
| Volume: | 91,241 |
| Market Cap: | 34(M) |
| PE Ratio: | -6.45 |
| Exchange: | New York Stock Exchange American |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.48 |
| Resistance 1: | 0.41 |
| Pivot price: | 0.37 |
| Support 1: | 0.30 |
| Support 2: | 0.25 |
| 52w High: | 0.97 |
| 52w Low: | 0.22 |
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Wed, 27 May 2026
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures - The Manila Times
Wed, 27 May 2026
Milestone Scientific Inc. Reports Increased Adoption of CompuFlo® Epidural System Following Positive Research Findings from University of Texas Medical Branch - Quiver Quantitative
Wed, 27 May 2026
Epidural-guiding device cuts SCS complications by 91% in UTMB study - Stock Titan
Thu, 14 May 2026
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2026 Earnings Conference - Moomoo
Thu, 14 May 2026
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations - Investing.com
Thu, 14 May 2026
Full Transcript: Milestone Scientific Q1 2026 Earnings Call - Sahm
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |